EpilepsyGTx

EpilepsyGTx is a biotechnology company focused on developing cutting-edge gene therapies for the treatment of focal drug-resistant epilepsy, with the mission to make patients with focal drug-resistant epilepsy seizure-free. The company is developing a series of advanced gene therapies based on groundbreaking research from the Queen Square Institute of Neurology at University College London.